Our report further emphasizes the need for a comprehensive integrated approach to differentiate between nodal NMZL with a significant expansion of reactive PD1+ T-cells and primary PTCL-TFH [13,14,15,16,17,18,19,21]. The gene discussed is PDCD1; the disease is nodal marginal zone B-cell lymphoma.